UW Carbone Cancer Center receives ‘outstanding’ grade on renewal
Every five years, the UW Carbone Cancer Center receives a thorough check-up from the nation’s top cancer researchers. Leaders recently learned that it passed its review with flying colors and will retain its designation as Wisconsin’s only National Cancer Institute (NCI) Comprehensive Cancer Center and $27 million in core funding.
Dense breasts and inflammation further linked to breast cancer risk
A new study by University of Wisconsin Carbone Cancer Center researchers has found that dense breasts and inflammation are associated with poor prognosis in breast-cancer patients, and suggests that an FDA-approved drug may improve prognosis for those patients with dense breasts.
UW Health’s Abd-Elsayed named to Wisconsin Medical Examining Board
Alaa Abd-Elsayed, MD, has been appointed as one of 10 licensed doctors on the Wisconsin Medical Examining Board.
UW Carbone study: Caregiver spouses of cancer patients suffer untreated depression
A new study from the University of Wisconsin Carbone Cancer Center highlights a troubling disparity in cancer care: the depressed spouses of cancer patients are 33 percent less likely to receive adequate treatment for depression than are patients whose spouses don’t have cancer. In rural areas, it’s even worse: Couples who live in rural areas are 72 percent less likely to receive recommended care for depression (including medication and talk therapy) than the depressed spouses of those without cancer.
The Ride funds $352,000 in cancer research at Carbone Cancer Center
Research efforts at the University of Wisconsin Carbone Cancer Center received a $352,000 boost this weekend when The Ride announced the winners of 14 scholarships during the Badger hockey game Saturday night.
Viral replication discovery could spur new broad-spectrum antivirals
Scientists at the Morgridge Institute for Research have discovered a new Achilles heel in the replication process of positive-strand RNA viruses, a class responsible for health threats such as Zika, polio, chikungunya and hepatitis C.
Allan Brasier to lead Institute for Clinical and Translational Research
The University of Wisconsin–Madison has recruited a leading physician-scientist to direct its Institute for Clinical and Translational Research (ICTR) after the founding leader retires.
UW study advances gene therapy for glaucoma
While testing genes to treat glaucoma by reducing pressure inside the eye, University of Wisconsin–Madison scientists stumbled onto a problem: They had trouble getting efficient gene delivery to the cells that act like drains to control fluid pressure in the eye.
Sheri Johnson named Population Health Institute director
The UW School of Medicine and Public Health has selected a leading advocate for health equity as the new director of its Population Health Institute.
Changes to the gut microbiome associated with structural changes in the brain
Diet-dependent changes in the gut microbiome of rats are associated with corresponding structural changes in their brains, according to a new study by researchers at the University of Wisconsin School of Medicine and Public Health.
Study provides a potential therapeutic strategy for aggressive lymphoma
Researchers at the University of Wisconsin School of Medicine and Public Health have found a molecular regulator that controls cell life in diffuse large B cell lymphoma, the most common, aggressive form of lymphoma.
Swallowing problems increase risk of death, nursing home admissions
Patients with trouble swallowing following a stroke or other medical event are more likely to die in the hospital, and had longer and more expensive hospital stays, according to analysis led by researchers from the University of Wisconsin School of Medicine and Public Health.